Skip to main content
PMC home page
Brain Pathology logoLink to Brain Pathology
. 2006 Apr 5;12(4):405–411. doi: 10.1111/j.1750-3639.2002.tb00457.x

Excitatory Amino Acid Transporter EAAT‐2 in Tangle‐bearing Neurons in Alzheimer's Disease

Dietmar Rudolf Thal 1,✉
PMCID: PMC8095978  PMID: 12408226

Abstract

The excitatory amino acid transporter EAAT‐2 is physiologically expressed in astrocytes. This study demonstrates that distinct subclasses of neurons exhibited EAAT‐2 immunoreactivity in cases with Alzheimer's disease (AD). EAAT‐2 was identified in the following types of neurons: Cortical pyramidal cells, fascia dentata granule cells, neurons of the basal nucleus of Meynert, the substantia nigra, the paraventricular nucleus of the hypothalamus, oral and central raphe nuclei, locus coeruleus, parabrachial nucleus, and neurons of the reticular formation of the brain stem. All EAAT‐2‐positive neurons displayed cytoskeletal abnormalities with abnormal Γ‐protein and often showed condensed and shrunken nuclei. None of the control cases without AD‐related pathology showed EAAT‐2‐immunoreactive neurons. These results indicate that AD‐related neurodegeneration is associated with the expression of the glutamate transporter EAAT‐2 in altered neurons. Since an aberrant expression of EAAT‐1 in neurons has recently been described, the finding of a neuronal expression of EAAT‐2 strongly supports the hypothesis that abnormalities in the glutamate transport play an important role in the pathogenesis of AD.

Full Text

The Full Text of this article is available as a PDF (277.0 KB).

References

  • 1. Beckstrom H, Julsrud L, Haugeto O, Dewar D, Graham DI, Lehre KP, Storm‐Mathisen J, Danbolt NC (1999) Interindividual differences in the levels of the glutamate transporters GLAST and GLT, but no clear correlation with Alzheimer's disease. J Neurosci Res 55:218–229. [DOI] [PubMed] [Google Scholar]
  • 2. Braak H, Braak E (1991) Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol 1:213–216. [DOI] [PubMed] [Google Scholar]
  • 3. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer‐related changes. Acta Neuropathol 82:239–259. [DOI] [PubMed] [Google Scholar]
  • 4. Cotman CW, Monaghan DT, Ottersen OP, Storm‐Mathisen J (1987) Anatomical organization of excitatory amino acid receptors and their pathways. Trends Neurosci 10:273–280. [Google Scholar]
  • 5. De Boni U, McLachlan DR (1985) Controlled induction of paired helical filaments of the Alzheimer type in cultured human neurons, by glutamate and aspartate. J Neurol Sci 68:105–118. [DOI] [PubMed] [Google Scholar]
  • 6. Esiri MM, Hyman BT, Beyreuther K, Masters CL (1997) Ageing and Dementia In: Greenfields Neuropathology, vol 2, Graham DI, Lantos PL (eds) Arnold, London , pp 153–233. [Google Scholar]
  • 7. Fray AE, Ince PG, Banner SJ, Milton ID, Usher PA, Cookson MR, Shaw PJ (1998) The expression of the glial glutamate transporter protein EAAT2 in motor neuron disease: an immunohistochemical study. Eur J Neurosci 10:2481–2489. [DOI] [PubMed] [Google Scholar]
  • 8. Greenamyre JT, Porter RH (1994) Anatomy and physiology of glutamate in the CNS. Neurology 44:S7–13. [PubMed] [Google Scholar]
  • 9. Harris ME, Wang Y, Pedigo NW, Jr. , Hensley K, Butterfield DA, Carney JM (1996) Amyloid beta peptide (25–35) inhibits Na+‐dependent glutamate uptake in rat hippocampal astrocyte cultures. J Neurochem 67:277–286. [DOI] [PubMed] [Google Scholar]
  • 10. Hsu SM, Raine L, Fanger H (1981) Use of avidin‐biotinperoxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577–580. [DOI] [PubMed] [Google Scholar]
  • 11. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140:566–572. [DOI] [PubMed] [Google Scholar]
  • 12. Iqbal K, Braak H, Braak E, Grundke‐Iqbal I (1993) Silver labeling of Alzheimer neurofibrillary changes and brain β‐amyloid. J Histotechnol 16:335–342. [Google Scholar]
  • 13. Jicha GA, Lane E, Vincent I, Otvos L, Jr. , Hoffmann R, Davies P (1997) A conformation‐ and phosphorylation‐dependent antibody recognizing the paired helical filaments of Alzheimer's disease. J Neurochem 69:2087–2095. [DOI] [PubMed] [Google Scholar]
  • 14. Kanai Y, Hediger MA (1992) Primary structure and functional characterization of a high‐affinity glutamate transporter. Nature 360:467–471. [DOI] [PubMed] [Google Scholar]
  • 15. Kanai Y, Smith CP, Hediger MA (1993) The elusive transporters with a high affinity for glutamate. Trends Neurosci 16:365–370. [DOI] [PubMed] [Google Scholar]
  • 16. Li S, Mallory M, Alford M, Tanaka S, Masliah E (1997) Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression. J Neuropathol Exp Neurol 56:901–911. [DOI] [PubMed] [Google Scholar]
  • 17. Marx J (2000) Alzheimer's congress. Drug shows promise for advanced disease. Science 289:375–377. [DOI] [PubMed] [Google Scholar]
  • 18. Masliah E, Alford M, DeTeresa R, Mallory M, Hansen L (1996) Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease. Ann Neurol 40:759–766. [DOI] [PubMed] [Google Scholar]
  • 19. Masliah E, Alford M, Mallory M, Rockenstein E, Moechars D, Van Leuven F (2000) Abnormal glutamate transport function in mutant amyloid precursor protein transgenic mice. Exp Neurol 163:381–387. [DOI] [PubMed] [Google Scholar]
  • 20. Milton ID, Banner SJ, Ince PG, Piggott NH, Fray AE, Thatcher N, Horne CH, Shaw PJ (1997) Expression of the glial glutamate transporter EAAT2 in the human CNS: an immunohistochemical study. Brain Res Mol Brain Res 52:17–31. [DOI] [PubMed] [Google Scholar]
  • 21. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, Van Belle G, Berg L (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479–486. [DOI] [PubMed] [Google Scholar]
  • 22. Nagao S, Kwak S, Kanazawa I (1997) EAAT4, a glutamate transporter with properties of a chloride channel, is predominantly localized in Purkinje cell dendrites, and forms parasagittal compartments in rat cerebellum. Neuroscience 78:929–933. [DOI] [PubMed] [Google Scholar]
  • 23. Paxinos G (1990) The human nervous system. Academic Press, San Diego . [Google Scholar]
  • 24. Pines G, Danbolt NC, Bjoras M, Zhang Y, Bendahan A, Eide L, Koepsell H, Storm‐Mathisen J, Seeberg E, Kanner BI (1992) Cloning and expression of a rat brain L‐glutamate transporter. Nature 360:464–467. [DOI] [PubMed] [Google Scholar]
  • 25. Rothstein JD, Van Kammen M, Levey AI, Martin LJ, Kuncl RW (1995) Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis. Ann Neurol 38:73–84. [DOI] [PubMed] [Google Scholar]
  • 26. Sautiere PE, Sindou P, Couratier P, Hugon J, Wattez A, Delacourte A (1992) Tau antigenic changes induced by glutamate in rat primary culture model: a biochemical approach. Neurosci Lett 140:206–210. [DOI] [PubMed] [Google Scholar]
  • 27. Schmitt A, Asan E, Puschel B, Kugler P (1997) Cellular and regional distribution of the glutamate transporter GLAST in the CNS of rats: nonradioactive in situ hybridization and comparative immunocytochemistry. J Neurosci 17:1–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Scott HL, Pow DV, Tannenberg AE, Dodd PR (2002) Aberrant expression of the glutamate transporter excitatory amino acid transporter 1 (EAAT1) in Alzheimer's disease. J Neurosci 22:RC206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Storck T, Schulte S, Hofmann K, Stoffel W (1992) Structure, expression, and functional analysis of a Na(+)‐dependent glutamate/aspartate transporter from rat brain. Proc Natl Acad Sci U S A 89:10955–10959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Thal DR, Rub U, Orantes M, Braak H (2002) Phases of Aß‐deposition in the human brain and its relevance for the development of AD. Neurology 58:1781–1800. [DOI] [PubMed] [Google Scholar]
  • 31. Thal DR, Rub U, Schultz C, Sassin I, Ghebremedhin E, Del Tredici K, Braak E, Braak H (2000) Sequence of Abeta‐protein deposition in the human medial temporal lobe. J Neuropathol Exp Neurol 59:733–748. [DOI] [PubMed] [Google Scholar]
  • 32. Thal DR, Sassin I, Schultz C, Haass C, Braak E, Braak H (1999) Fleecy amyloid deposits in the internal layers of the human entorhinal cortex are comprised of N‐terminal truncated fragments of Abeta. J Neuropathol Exp Neurol 58:210–216. [DOI] [PubMed] [Google Scholar]
  • 33. The National Institute on Aging (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging 18:S1–2. [PubMed] [Google Scholar]
  • 34. Winblad B, Poritis N (1999) Memantine in severe dementia: results of the 9M‐Best Study (Benefit and efficacy in severely demented patients during treatment with memantine). Int J Geriatr Psychiatry 14:135–146. [DOI] [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES